We also offer tools for the diagnosis, prognosis, and monitoring of inflammatory and related diseases, which provide doctors with the answers they need to give their patients the right treatment at the right time.
So, whether you are helping patients by developing new drugs or diagnosing disease, we can help you get the answers you need. It’s in our name.
Our Product & Service Highlights
- iLite® CELL-BASED SOLUTIONS →
Explore the cell-based iLite reporter gene technology, modified and adapted for applications during the whole drug development continuum as well as for monitoring of biological drugs.
- COMPLEMENT SYSTEM SOLUTIONS →
Explore every angle of the complement system using our portfolio of cell-based reporter-gene assays, functional and biomarker assays as well as flexi solutions – for automated platforms of your choice
- CALPROTECTIN SOLUTIONS →
Under the Calpro brand, we offer high-quality total solutions for Calprotectin analysis. From fully automated systems and lab tests to rapid point-of-care tests for home monitoring of patients with IBD.
- BIOANALYTICAL SERVICES →
Through our specialized CRO we answer to the complexities of large molecules (biologics and biosimilars). We provide services for non-clinical, clinical Phase I-III, post-marketing studies and offer support in planned and ongoing drug development projects.
- WIESLAB DIAGNOSTIC SERVICES →
We help our customers with clinical testing, provide testing services and support for therapeutic drug monitoring. Our request forms list test panels and individual markers within the areas of Autoimmune Diagnostics, Neurology, Monitoring of Biopharmaceuticals, and Genetic testing.
- CUSTOM DEVELOPMENT →
Our custom development services are renowned as highly reliable and innovative, tailored to our customers’ assay development and manufacturing needs. We offer versatile assay solutions to pharma, biotech, and CRO customers, as well as to our partners within diagnostics.
We answer to your needs and our goal is to make a difference in your drug development project.